Skip to content

VORBO HORIZON Pharmaceuticals Pvt Ltd

  • by

A product by HORIZON Pharma

Horizon pharmaceuticals private limited your health’s companion with years of your trust and confidence vorbovordioccidine 10 milligrams and 20 milligrams tablets available in affordable prices 10 milligrams in rupees 25 per tablet and 20 milligrams in rupees 40 per tablet paradigm shift in depression treatment help yourself to be cheerful with vorbovordioccidine

Horizon introducing nation’s first vordioxidine brand the most powerful antidepressant vorbo vortioxidine mode of action serotonin receptor modulator serotonin transporter inhibitor vordioxidine acts as a 5 ht1a receptor agonist 5 ht35ht7 and 5 ht1d receptor antagonist 5 ht1b receptor partial agonist and inhibitor of the 5 ht transporter pharmacokinetics oral

Bioavailability 75 time to peak plasma concentration 7 to 11 hours metabolic pathway with subsequent glucuronic acid conjugation half-life approximately 66 hours protein binding 98 elimination approximately 59 percent through urine and 26 through feces vorbo vortioxidine a multimodal antidepressant vorbo vortioxidine through 5 ht3 receptor antagonism enhance the

Release of procognitive neurotransmitters including norepinephrine acetylcholine and serotonin 5 ht within various brain circuits vorbo vortioxidine effective switch therapy in major depressive disorder patients vorbo vordioxidine is an effective switch therapy for patients with major depressive disorder whose response to selective serotonin reuptake inhibitor and

Serotonin norepinephrine reuptake inhibitors therapy is inadequate vorbo vordioxidine a superior antidepressant vorbo vortioxidine was numerically better than all included antidepressants with statistically significant differences versus e citalopram and norepinephrine vorbo vordioxidine in generalized anxiety disorder vorbo vortioxidine the beneficial effects of

Vortioxidine on anxiety symptoms functioning and quality of life are greater in adults who are working and pursuing an education vordioxidine was efficacious in reducing depressive and anxiety symptoms in patients with major depressive disorder and high levels of anxiety vorbo vortioxidine improved sexual functioning vorbo vortioxidine is a safe and effective

Switch therapy for treating selective serotonin reuptake inhibitor-induced sexual dysfunction vorbo vortioxidine better cognitive function vorbo vortioxidine effectively improved cognitive function in major depressive disorder patients as compared to other antidepressants vorbo vordioxidine in ischemic stroke vorbo vortioxidine is significantly reduces the

Severity of depressive symptoms by improving neurodynamic functions and memory in patients in the early recovery period of ischemic stroke vorbo vortioxidine in cerebrovascular disease vorbo vortioxidine is a strong candidate for use in depression associated with cerebrovascular disease vorbo vortioxidine safety in cardiovascular parameters vorbo vordioxidine

Had no effect relative to placebo on clinical laboratory parameters body weight heart rate or blood pressure with no clinically relevant effect on ecg parameters including the qtcf interval vorbo vortioxidine use in pregnancy and lactation pregnancy exposure to serotonergic antidepressants in late pregnancy may lead to an increased risk for neonatal complications

Requiring prolonged hospitalization respiratory support and tube feeding lactation there is no information regarding presence of vorbo in human milk effects on the breasted infant or effects on milk production vorbo vordioxidine is found to be present in rat milk developmental and health benefits of breast feeding should be considered along with mother’s clinical

Need for therapy and any potential adverse effects on breastfed child from therapy or from underlying maternal condition vorbo vortioxidine adrs contraindications and drug interactions adverse reactions nausea diarrhea dizziness dry mouth constipation vomiting flatulence pruritus and abnormal dreams contraindications vordioxidine is contraindicated in patients

Who are hypersensitive to vortioxidine or any of its components drug interaction the concomitant administration of vordioxidine and strong cyp2d6 inhibitors example bupropion fluoxetine peroxidine or quinidine may require 50 reduction in the vortioxidine dose when vortioxidine is co-administered with strong cyp inducer example rifampin carbamazepine or phenytoin

For more than 14 days an increased vortioxidine dose can be considered vorbo vordioxidine tablet is double scored generating multiple strengths vorbo available in 10 milligrams and 20 milligrams tablets vorbo unique selling points superior antidepressant then selective serotonin reuptake inhibitors serotonin norepinephrine reuptake inhibitors monoamine oxidase

Inhibitors and tricyclic antidepressants effective switch therapy for depression against existing antidepressants better cognitive profile better sexual performance profile better neurogenesis profile double scored and generate multiple strengths 10 milligrams and 20 milligrams both tablets can be broken and taken in breakup during the day as per doctor advice

Most affordable prices better cardiovascular safety help yourself to be cheerful vorbo indications major depressive disorder and anxiety dosage 10 milligrams orally once daily without regards to meal dosage can be increased up to 20 milligrams per day available in affordable prices 10 milligrams in rupees 25 per tablet and 20 milligrams in rupees 40 per tablet

Successful start of year 2021 three brands one company horizon pharmaceutical private limited first and number one ranked brands as per ims mat 01 2021 ampagliflozin as impa m-pa-m and empa-mx-r dexlansoprosol as dexo remde ziver as red z horizon pharmaceuticals always strive to introduce best treatment options in pakistan thank you for your support and time

Transcribed from video
VORBO HORIZON Pharmaceuticals Pvt Ltd By H4A Gohar